User menu

A health economic model to assess the cost-effectiveness of pegylated interferon α-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels

Bibliographic reference Gerkens, Sophie ; Nechelput, Myriam ; Annemans, Lieven ; Peraux, Bénédict ; Beguin, Claire ; et. al. A health economic model to assess the cost-effectiveness of pegylated interferon α-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels. In: Acta Gastro-Enterologica Belgica (Multilingual Edition), Vol. 70, no. 2, p. 177-187 (2007)
Permanent URL http://hdl.handle.net/2078.1/164695